Publications by authors named "Jerrold B Teitcher"

Claim this Profile
A
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
Lillian M Smyth, Kelsey R Monson, Komal Jhaveri, Alexander Drilon, Bob T Li, Jerrold B Teitcher

Invest New Drugs· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Revathy B Iyer

Gynecol Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer.
M Catherine Pietanza, Anya M Litvak, Anna M Varghese, Lee M Krug, Martin Fleisher, Jerrold B Teitcher

Lung Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition.
Richard D Carvajal, Donald P Lawrence, Jeffrey S Weber, Thomas F Gajewski, Rene Gonzalez, Jerrold B Teitcher

Clin Cancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors.
David M Hyman, Alexandra E Snyder, Richard D Carvajal, John F Gerecitano, Martin H Voss, Jerrold B Teitcher

Cancer Chemother Pharmacol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Svetlana Mironov

Gynecol Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity.
Timothy R Asmis, Ki Y Chung, Jerrold B Teitcher, David P Kelsen, Manish A Shah

Invest New Drugs· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
Dennis S Chi, Pedro T Ramirez, Jerrold B Teitcher, Svetlana Mironov, Debra M Sarasohn

J Clin Oncol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.
George Sgouros, Shannon Squeri, Ase M Ballangrud, Katherine S Kolbert, Jerrold B Teitcher

J Nucl Med· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis